Lulu McCartin Email

VP Commercial Operations . Provention Bio

Current Roles

Employees:
129
Revenue:
$15.7M
About
Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. -We seek technologies or targets designed to predict, preempt or intervene before immune disease begins, re-appears or progresses. -We are creating a new biopharmaceutical category for autoimmunity. We leverage a transformational drug development strategy that sources, repositions and advances candidates that: -Target the interception or prevention of immune-mediated disease -Have been underdeveloped or deprioritized because of insufficient clinical trial efficacy or for strategic reasons -Have demonstrated proof-of-mechanism by preventing or intercepting immunopathologic pathways We believe that our deep understanding of immune-mediated pathophysiology, experience in translational medicine, and expertise in the design of rapid go/no-go clinical trials enables us to identify and evaluate potential therapeutic candidates for acquisition or in-licensing.
Provention Bio Address
55 Broad Street
Oldwick, null
Provention Bio Email

Past Companies

Provention BioVice President Of Commercial Operations
Provention BioExecutive Director, Commercial Operations
SUN PHARMAMarket Insights & Analytics Team Lead

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.